Einstein Research

Research News

Drug Shows Promise Against Sudan Strain of Ebola in Mice

Drug Shows Promise Against Sudan Strain of Ebola in Mice

 

August 28, 2014 — (BRONX, NY) — Researchers from Albert Einstein College of Medicine of Yeshiva University and other institutions have developed a potential antibody therapy for Sudan ebolavirus (SUDV), one of the two most lethal strains of Ebola. A different strain, the Zaire ebolavirus (EBOV), is now devastating West ...read more

Other Top Stories

Using Physics to Design Better Drugs: Albert Einstein College of Medicine Awarded $9 Million NIH Grant

'Normal' Bacteria Vital for Keeping Intestinal Lining Intact

 

Research Spotlight

Rare Disease Research

Inspired by the children and families struggling with the rare brain disease Niemann-Pick C, Dr. Steven Walkley turned a serendipitous lab discovery into a promising therapy.

watch video | more multimedia

 

Research Round-Up

Making Sense of Microtubules — Dr. David Sharp has been awarded $1.2 million over four years to study the dynamic severing and rebuilding of microtubules that enables cells to move and divide. In collaboration with grant co-investigator Jennifer Ross of the University of Massachusetts at Amherst, Dr. Sharp will study how two poorly understood enzymes, Fidgetin and Fidgetin-like 2, severe microtubules along... read more

 

Lasers and Lung Cancer — Lung cancer tumors contain a variety of cells in addition to cancer cells. Using a technique known as Laser Capture Microdissection, Dr. Simon Spivack and colleagues, including lead authors Drs. Juan Lin and Gabrielle Marquardt, isolated individual cancer and non-cancer cells from patients with lung tumors and compared their gene expression profiles. The... read more

 

Diabetes and the Brain — In research published in the August 3 issue of Nature MedicineDr. Dongsheng Cai identifies a mechanism that may help explain the brain’s role in causing type 2 diabetes. Studying obese and aged mice—conditions associated with diabetes—Dr. Cai’s team found increased levels of a molecule called transforming growth factor beta (TGF-β) within the hypothalamus of their brains. Then, using... read more

view all

Einstein Experts

Dr. Roy Chuck

Dr. Roy Chuck
  • Eye disease
  • Dry eye

Dr. Chuck is a prominent stem cell and dry eye researcher and one of the youngest ophthalmology chairs in the ...read more

view Einstein Expert list

 

Recent Recruits

Dr. Wenjun GuoDr. Wenjun Guo
Assistant Professor
Cell Biology

Dr. Guo joins Einstein from Weill Cornell Graduate School of Medical Sciences. more

He notes, "My lab is interested in two interlocking areas of stem cell biology: the molecular pathways that regulate the normal stem-cell state in the mammary gland, and the role of these pathways in the regulation of breast cancer stem cells." Dr. Guo's profile